Prognostic Indicators After Salvage Surgery for Brain Metastases Progression Post-Radiotherapy
Overview
This study evaluated outcomes of salvage surgery in 49 patients with local progression of brain metastases following radiotherapy. Non-small cell lung cancer was the most common primary tumor, and most patients had prior stereotactic radiosurgery or radiotherapy. Salvage surgery was performed based on multidisciplinary assessment, with histological confirmation distinguishing recurrence from radiation necrosis.
Background
Brain metastases affect 8%–10% of cancer patients and are associated with poor prognosis. Advances in cancer treatment have increased patient survival, leading to more cases of brain metastases and local progression after radiotherapy. Treatment options include surgery, radiotherapy, and systemic therapy, but local therapies remain crucial due to limited efficacy of systemic agents. Salvage surgery is increasingly used for local progression but its outcomes have not been well characterized.
Data Highlights
Characteristic
Value
Number of patients
49
Most common primary cancer
Non-small cell lung cancer (55%)
History of SRS
69%
History of SRT
28%
History of WBRT
6%
Re-irradiation before salvage surgery
12%
Radiotherapies at referral hospitals
17 of 55
Key Findings
Salvage surgery was indicated for lesions enlarging on imaging or causing neurological symptoms post-radiotherapy.
Histological diagnosis differentiated recurrence (viable cancer cells) from radiation necrosis.
Most patients had prior stereotactic radiosurgery or radiotherapy, with a minority receiving whole-brain radiotherapy.
Re-irradiation prior to salvage surgery was performed in 12% of patients.
Multidisciplinary evaluation was essential for surgical candidacy, considering life expectancy and absence of leptomeningeal or uncontrolled intracranial metastases.
Clinical Implications
Salvage surgery can be a valuable treatment option for patients with local progression of brain metastases after radiotherapy, especially when lesions enlarge or cause symptoms. Accurate histopathological diagnosis is critical to distinguish recurrence from radiation necrosis, guiding appropriate management. Multidisciplinary assessment ensures optimal patient selection, balancing potential benefits with systemic disease status and life expectancy.
Conclusion
Salvage surgery following radiotherapy for brain metastases local progression shows promise in selected patients, with outcomes influenced by histological findings and clinical factors. Further studies are needed to refine prognostic indicators and optimize treatment strategies.
References
Nieder et al. 2018 -- Brain metastases: epidemiology and treatment
Patchell et al. 1990 -- Surgical resection of brain metastases
Gaspar et al. 1997 -- Recursive Partitioning Analysis (RPA) classification
Kocher et al. 2011 -- Radiotherapy for brain metastases
